GlyCosmos Portal

GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source	Last Updated
GlycoNAVI Proteins	November 21, 2024

Displaying entries **5101 - 5150** of **39437** in total

« First

‹ Prev

…

99

100

101

102

103

104

105

106

107

…

Next ›

Last »
PDB ID ▼	UniProt ID	Title
8D2U	Q6DEJ6	Zebrafish MFSD2A isoform B in inward open ligand 1A conformation
8D2U	8D2U	Zebrafish MFSD2A isoform B in inward open ligand 1A conformation
8D2T	Q6DEJ6	Zebrafish MFSD2A isoform B in inward open ligand-free conformation
8D2T	8D2T	Zebrafish MFSD2A isoform B in inward open ligand-free conformation
8D2S	Q6DEJ6	Zebrafish MFSD2A isoform B in inward open ligand bound conformation
8D2S	8D2S	Zebrafish MFSD2A isoform B in inward open ligand bound conformation
8D21	Q6WG00	Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer
8D21	Q289M7	Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer
8D21	8D21	Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer
8D0Z	P0DTC2	S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement)
8D0Z	8D0Z	S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement)
8D0Y	8D0Y	Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and interface targeting antibody 35O22 at 4.7 Angstrom
8D0X	Q9Y231	Human FUT9 bound to LNnT
8D0W	Q9Y231	Human FUT9 bound to H-Type 2
8D0U	Q9Y231	Human FUT9 bound to GDP
8D0S	Q9Y231	Human FUT9 bound to GDP and LNnT
8D0R	Q9Y231	Human FUT9 bound to GDP and H-Type 2
8D0Q	Q9Y231	Human FUT9 bound to GDP-CF3-Fucose and H-Type 2
8D0P	Q9Y231	Human FUT9, unliganded
8D0O	Q9Y231	Human alpha1,3-fucosyltransferase FUT9, heavy atom derivative
8CZZ	A0A6C0ZY47	Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer with LMHS mutations in complex with Temsavir, 8ANC195, and 10-1074
8CZZ	8CZZ	Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer with LMHS mutations in complex with Temsavir, 8ANC195, and 10-1074
8CYH	8CYH	Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics
8CYH	Q13421	Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics
8CYB	P0DTC2	SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
8CYB	8CYB	SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
8CYA	P0DTC2	SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67
8CYA	8CYA	SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67
8CY7	P0DTC2	SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
8CY7	8CY7	SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
8CXN	P0DTC2	SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
8CXN	8CXN	SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
8CXI	A0A142DS37	Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy
8CXI	Q9H9E1	Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy
8CXI	A0A1S6LXE0	Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy
8CXI	8CXI	Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy
8CX3	Q13421	Crystal structure of full-length mesothelin
8CWV	P0DTC2	Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab
8CWV	8CWV	Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab
8CWU	P0DTC2	Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21
8CWU	8CWU	Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21
8CWK	8CWK	Fab arm of antibodies 4G1-C2 and 10G4 bound to CoV-2 receptor binding domain (RBD)
8CWK	Q6GMX0	Fab arm of antibodies 4G1-C2 and 10G4 bound to CoV-2 receptor binding domain (RBD)
8CWK	P0DTC2	Fab arm of antibodies 4G1-C2 and 10G4 bound to CoV-2 receptor binding domain (RBD)
8CWJ	8CWJ	Fab arms of antibodies 4C12-B12 and CR3022 bound to pangolin receptor binding domain (pRBD)
8CWJ	A0A7D6TQ96	Fab arms of antibodies 4C12-B12 and CR3022 bound to pangolin receptor binding domain (pRBD)
8CWI	P0DTC2	Fab arm of antibody 10G4 bound to CoV-2 receptor binding domain (RBD)
8CWI	8CWI	Fab arm of antibody 10G4 bound to CoV-2 receptor binding domain (RBD)
8CWH	P00698	200us Temperature-Jump (Dark2) XFEL structure of Lysozyme Bound to N,N'-diacetylchitobiose
8CWG	P00698	200us Temperature-Jump (Dark1) XFEL structure of Lysozyme Bound to N,N'-diacetylchitobiose

Download data in CSV format Download data in TSV format Download data in JSON format

Table Filtering

GlyTouCan

GlyComb

GlycoPOST

UniCarb-DR

All Resources

Other Information

Tools

Search Tools

International Collaboration

Acknowledgements